CN113633685A - Traditional Chinese medicine composition with antibacterial activity and application - Google Patents
Traditional Chinese medicine composition with antibacterial activity and application Download PDFInfo
- Publication number
- CN113633685A CN113633685A CN202111063207.XA CN202111063207A CN113633685A CN 113633685 A CN113633685 A CN 113633685A CN 202111063207 A CN202111063207 A CN 202111063207A CN 113633685 A CN113633685 A CN 113633685A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- medicine composition
- bacteriostatic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 116
- 239000000203 mixture Substances 0.000 title claims abstract description 84
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 37
- 230000003385 bacteriostatic effect Effects 0.000 claims abstract description 49
- 239000007921 spray Substances 0.000 claims abstract description 9
- 239000000344 soap Substances 0.000 claims abstract description 4
- 241000205585 Aquilegia canadensis Species 0.000 claims description 27
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 24
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 24
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 24
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 24
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 24
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 24
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 24
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 24
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 24
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 24
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 24
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 24
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 24
- 240000004534 Scutellaria baicalensis Species 0.000 claims description 24
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 23
- 241000334160 Isatis Species 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 238000010438 heat treatment Methods 0.000 claims description 11
- 239000012153 distilled water Substances 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 8
- 240000006079 Schisandra chinensis Species 0.000 claims description 8
- 235000008422 Schisandra chinensis Nutrition 0.000 claims description 8
- 235000017803 cinnamon Nutrition 0.000 claims description 8
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 5
- 239000002552 dosage form Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 2
- 238000002347 injection Methods 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 240000000171 Crataegus monogyna Species 0.000 claims 3
- 244000170916 Paeonia officinalis Species 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 abstract description 36
- 241000588724 Escherichia coli Species 0.000 abstract description 19
- 241000191967 Staphylococcus aureus Species 0.000 abstract description 18
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 16
- 241000222122 Candida albicans Species 0.000 abstract description 7
- 239000010231 banlangen Substances 0.000 abstract description 7
- 229940095731 candida albicans Drugs 0.000 abstract description 7
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 7
- 230000002829 reductive effect Effects 0.000 abstract description 5
- 206010059866 Drug resistance Diseases 0.000 abstract description 4
- 241000628997 Flos Species 0.000 abstract description 3
- 230000001580 bacterial effect Effects 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 231100000419 toxicity Toxicity 0.000 abstract description 3
- 230000001988 toxicity Effects 0.000 abstract description 3
- 238000011161 development Methods 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract description 2
- 238000000605 extraction Methods 0.000 abstract description 2
- 230000036541 health Effects 0.000 abstract description 2
- 241000894006 Bacteria Species 0.000 description 29
- 230000005764 inhibitory process Effects 0.000 description 23
- 238000012360 testing method Methods 0.000 description 22
- 241001092040 Crataegus Species 0.000 description 21
- 229920001817 Agar Polymers 0.000 description 18
- 239000008272 agar Substances 0.000 description 18
- 239000000243 solution Substances 0.000 description 16
- 239000011550 stock solution Substances 0.000 description 12
- 239000011248 coating agent Substances 0.000 description 11
- 238000000576 coating method Methods 0.000 description 11
- 238000012258 culturing Methods 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 10
- 230000001954 sterilising effect Effects 0.000 description 10
- 238000001514 detection method Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000006916 nutrient agar Substances 0.000 description 6
- 238000004080 punching Methods 0.000 description 6
- 241001106477 Paeoniaceae Species 0.000 description 5
- 230000002147 killing effect Effects 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 241000555712 Forsythia Species 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- 239000000022 bacteriostatic agent Substances 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 238000003113 dilution method Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 238000002791 soaking Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 241000576429 Forsythia suspensa Species 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- -1 hand sanitizer Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Birds (AREA)
- Zoology (AREA)
- Insects & Arthropods (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Neurosurgery (AREA)
- Animal Husbandry (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention belongs to the field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition with antibacterial activity and application thereof. The Chinese medicinal composition with antibacterial activity comprises Scutellariae radix, flos Lonicerae, radix Isatidis, fructus forsythiae, fructus crataegi, herba Menthae, and Galla chinensis; the traditional Chinese medicine composition has obvious bacteriostatic effect on staphylococcus aureus, escherichia coli and candida albicans, and the bacteriostatic effect is superior to that of a single traditional Chinese medicine; the toxicity and the bacterial drug resistance are reduced while the dosage of the drug is reduced; the traditional Chinese medicine composition has high stability, and is simple to operate, low in production cost, high in extraction rate and convenient to produce and apply; the provided traditional Chinese medicine composition can be used for preparing disinfection products and health products, including hand sanitizer, spray, bacteriostatic soap and the like with bacteriostatic functions, so that the range and the depth of development and application of traditional Chinese medicines are expanded, meanwhile, bacteriostatic components of the traditional Chinese medicines are applied to the products, and the technology has wide market application prospect and is certainly favored by consumers.
Description
Technical Field
The invention belongs to the field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition with antibacterial activity and application thereof.
Background
The traditional Chinese medicine bacteriostatic agent can prevent and treat diseases, disinfect and clean air, has few adverse reactions and does not need to add any chemical reagent. So far, a plurality of scholars show that a plurality of traditional Chinese herbal medicines have obvious antibacterial and antiviral effects through modern pharmacological research, the traditional Chinese medicine bacteriostatic agent makes new progress in the field of disinfection, and the application of the traditional Chinese medicine in the bacteriostatic agent not only opens up the traditional Chinese medicine source, but also expands the application range of the traditional Chinese medicine. The traditional Chinese medicine bacteriostatic agent is natural in material, safe, nontoxic and aromatic in smell. Some traditional Chinese medicine components have multiple target points and obvious in-vitro antiviral and antibacterial effects, can effectively inhibit the replication of the disease source and block the spread of the disease source, have wide application value, and are not easy to generate drug resistance due to the synergistic effect of multiple components in the formula. The traditional Chinese medicine disinfectant has the characteristics of low toxicity, mild bacteriostasis and wide bacteriostasis spectrum, and can be well popularized.
Pathogenic microorganism refers to microorganism which can invade human body and cause infection and even infectious disease, or pathogen, and belongs to the pathogenic factors of insect pathogen in exogenous pathogenic factors in traditional Chinese medicine. The parasites have the property of fleeing away and are related to wind pathogen, and ancient people mostly think that wind, damp-heat, dirty and other environments are easy to generate parasites, which are the important causes of the parasites, as in Yi Zong jin Jian, Xuan: "this syndrome always affects the skin by wind-heat and dampness, and is transformed into worms due to long-term wind, also known as Keqin: the Chinese medicine uses pungent and pungent substances for dispelling wind, bitter and dry for eliminating dampness, heat-clearing and detoxicating, sour and astringent substances for removing pathogenic microorganisms.
The invention provides a traditional Chinese medicine composition with a remarkable antibacterial effect, which comprises scutellaria baicalensis, honeysuckle, isatis root, fructus forsythiae, hawthorn, mint and gallnut; the traditional Chinese medicine composition has better antibacterial effect than a single traditional Chinese medicine; is helpful for reducing the dosage of the medicine, toxicity and bacterial drug resistance.
Disclosure of Invention
Aiming at the technical problems, the invention provides a traditional Chinese medicine composition with bacteriostatic activity, which specifically comprises the following contents:
in a first aspect, the invention provides a traditional Chinese medicine composition with bacteriostatic activity, which comprises the following components in parts by mass: 1-2 parts of scutellaria baicalensis, 1-2 parts of honeysuckle, 1-2 parts of isatis root, 1-2 parts of fructus forsythiae, 1-2 parts of hawthorn, 1-2 parts of mint and 1-2 parts of gallnut.
Preferably, the traditional Chinese medicine composition comprises the following components in parts by mass: 2 parts of scutellaria baicalensis, 1 part of honeysuckle, 2 parts of isatis root, 2 parts of fructus forsythiae, 1 part of hawthorn, 1 part of mint and 2 parts of gallnut.
Preferably, the traditional Chinese medicine composition also comprises the following components in parts by mass: 1-2 parts of schisandra chinensis, 1-2 parts of cinnamon and 1-2 parts of white paeony root.
Preferably, the composition comprises the following components in parts by mass: 2 parts of scutellaria baicalensis, 1 part of honeysuckle, 2 parts of isatis root, 2 parts of fructus forsythiae, 1 part of hawthorn, 1 part of mint, 2 parts of gallnut, 1 part of schisandra chinensis, 1 part of cinnamon and 1 part of radix paeoniae alba.
In a second aspect, the present invention provides a method for preparing the traditional Chinese medicine composition of the first aspect, wherein the method comprises: boiling the Chinese medicinal composition in water; filtering; heating and concentrating the filtrate to obtain the product.
Preferably, the method comprises the steps of:
(1) taking the Chinese medicinal composition, adding ten times of distilled water, heating with strong fire to boil, and heating with slow fire for 1 hr;
(2) filtering, taking the dregs of a decoction, adding ten times of distilled water, and flushing back to the step (1);
(3) filtering, mixing filtrates, heating and concentrating to 1g/mL, standing at room temperature for 24h, centrifuging to obtain supernatant, and autoclaving.
In a third aspect, the invention provides an application of the traditional Chinese medicine composition of the first aspect in preparing antibacterial drugs.
In a fourth aspect, the present invention provides a pharmaceutical acceptable carrier added to the traditional Chinese medicine composition of the first aspect to prepare any pharmaceutically acceptable dosage form.
Preferably, the dosage form comprises tablets, injections, oral liquids and sprays.
In a fifth aspect, the invention provides an application of the traditional Chinese medicine composition in the first aspect in preparing a hand sanitizer, bacteriostatic soap, cosmetics, health food and health products.
The invention has the beneficial effects that: the invention provides a traditional Chinese medicine composition with antibacterial activity, which comprises scutellaria baicalensis, honeysuckle, isatis root, fructus forsythiae, hawthorn, mint and gallnut; secondly, the traditional Chinese medicine composition has obvious bacteriostatic effect on staphylococcus aureus, escherichia coli and candida albicans, and the bacteriostatic effect is better than that of a single traditional Chinese medicine; the dosage of the medicine is reduced, and the toxicity and the bacterial drug resistance are reduced; the traditional Chinese medicine composition has good bacteriostatic effect, high stability, simple operation, low production cost, high extraction rate and convenient production and application; the traditional Chinese medicine composition can be used for preparing disinfection and killing products, including hand sanitizer, spray, bacteriostatic soap and the like with bacteriostatic functions, so that the range and the depth of development and application of traditional Chinese medicines are expanded, meanwhile, bacteriostatic components of the traditional Chinese medicines are applied to the products, and the technology has wide market application prospect and is certainly favored by consumers.
Drawings
The spray prepared in figure 1.
Detailed Description
The following detailed description of the present invention is provided in connection with specific examples, but it should be noted that the present invention is not limited to the following examples. All technical solutions which can be derived from a technical solution by a person skilled in the art through logical analysis, inference and experiment according to the technical solutions of the present invention are within the scope of the claimed invention.
Example 1 detection of bacteriostatic effects of Single Chinese medicine
1. Preparing a single traditional Chinese medicine extract:
weighing 50g of radix Scutellariae, flos Lonicerae, radix Isatidis, fructus forsythiae, fructus crataegi, herba Menthae, Galla chinensis, fructus Schisandrae chinensis, cortex Cinnamomi, and radix Paeoniae alba, respectively, adding into beaker, adding ten times of distilled water, heating with strong fire to boil, heating with slow fire, and stirring for 1 hr; filtering with 8 layers of gauze; taking the medicine residues, and pouring ten times of distilled water, wherein the steps are the same as the above steps; filtering, mixing filtrates, heating and concentrating to 1g/mL, standing at room temperature for 24h, centrifuging at 1000r/min for 5min, collecting supernatant, autoclaving, and storing at 4 deg.C.
2. Zone of inhibition detection
Adopting agar plate punching method, uniformly coating 100 μ L of test bacteria on nutrient agar, standing for 15min, uniformly punching on nutrient agar with a puncher with diameter of 6mm, removing agar block, adding Chinese medicinal or compound extractive solution containing crude drug 1g/mL into holes with liquid medicine overflow principle, 5 holes per plate, hole spacing >20mm, setting distilled water as negative control at center, setting positive control, culturing at 37 deg.C for 24 hr, determining diameter of antibacterial ring, observing result, and repeating the test for 3 times. The bacteriostatic diameter is more than or equal to 20mm, the bacteriostatic diameter is extremely sensitive, the bacteriostatic diameter is 15-19 mm, the bacteriostatic diameter is highly sensitive, the bacteriostatic diameter is 10-14 mm, the bacteriostatic diameter is moderate sensitive, and the bacteriostatic diameter is less than 10mm, the bacteriostatic diameter is low sensitive.
The results are shown in table 1, in the single traditional Chinese medicine, only gallnut, scutellaria baicalensis, honeysuckle and hawthorn have certain bacteriostatic activity on escherichia coli, staphylococcus aureus and candida albicans, and the isatis root, the forsythia suspensa and the mint are not sensitive to the bacteriostatic activity of the escherichia coli, the staphylococcus aureus and the candida albicans.
TABLE 1 diameter of inhibition zone (mm) of different Chinese medicinal aqueous extracts to detection bacteria
MIC and MBC determination
Using a puncher to perform high-pressure sterilization on a circular filter paper sheet of filter paper for later use; preparing a drug stock solution by a test tube double dilution method according to different concentrations of drugs in the circular filter paper sheets, wherein the stock solution concentration is as follows: 500. 250, 125, 62.5, 31.25, 15.62, 7.81 and 3.91mg/mL, and soaking the circular filter paper sheet with the medicine liquid with different concentrations; and (3) taking 100 mu L of test bacterium liquid to a formed blank agar plate, uniformly coating the test bacterium liquid by using a bacterium coating rod, and flatly and sequentially pasting filter paper sheets soaked with different liquid medicine concentrations to the agar plate after the bacterium suspension on the plate is completely absorbed. And culturing the mixture in an incubator which is internally provided with filter paper sheets and is subjected to ultraviolet sterilization at 37 ℃ for 18-24 h within 15min, and reading and measuring the result. Taking the lowest concentration of a drug stock solution which does not generate an inhibition zone around a filter paper sheet (namely, inhibits the growth of a tested bacterium) as the lowest inhibition concentration (MIC) of the drug solution, inoculating the concentration of a culture solution which is generated by the inhibition zone on all K-B paper sheet methods on an agar plate, culturing for 24h at 37 ℃, and taking the lowest drug mass concentration of which the colony count is not more than 5 as the minimum bactericidal mass concentration (MBC) of the drug (namely, the general name of the lowest concentration of the drug for killing a certain strain).
The results are shown in table 2, although the gallnut, the scutellaria baicalensis, the honeysuckle and the hawthorn in the single traditional Chinese medicine have bacteriostatic activity on escherichia coli, staphylococcus aureus and candida albicans below 500mg/mL, the bacteriostatic effect of the other single traditional Chinese medicine is not obvious; but except gallnut, the MBC of other single traditional Chinese medicines to escherichia coli, staphylococcus aureus and candida albicans is higher than 500mg/mL, and the sterilization effect is not obvious.
TABLE 2 MIC and MBC determination results (mg/mL) of single Chinese medicine for different bacteria
Example 2 Chinese medicine formulation screening
1. Preparation of Chinese medicinal composition with different proportions
Chinese medicinal compositions with different proportions are prepared according to the mass ratio shown in the following table 3.
TABLE 3 Mass ratio of the Chinese medicinal materials
| Forsythia fruit | Haw | Radix Isatidis | Galla chinensis | Honeysuckle | Radix Scutellariae | Mint | |
| Chinese medicinal composition 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Chinese medicinal composition 2 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Chinese medicinal composition 3 | 1 | 2 | 2 | 1 | 1 | 2 | 2 |
| Chinese medicinal composition 4 | 1 | 2 | 2 | 2 | 2 | 1 | 1 |
| Chinese medicinal composition 5 | 2 | 1 | 2 | 1 | 2 | 1 | 2 |
| Chinese medicinal composition 6 | 2 | 1 | 2 | 2 | 1 | 2 | 1 |
| Chinese medicinal composition 7 | 2 | 2 | 1 | 1 | 2 | 2 | 1 |
| Chinese medicinal composition 8 | 2 | 2 | 1 | 2 | 1 | 1 | 2 |
2. Results of orthogonal experiments
The results of orthogonal experiments on the antibacterial activity of escherichia coli are shown in table 4, and the antibacterial zone of a traditional Chinese medicine composition (crude drug dose is 1g/mL) prepared by combining scutellaria baicalensis, honeysuckle, isatis root, fructus forsythiae, hawthorn, mint and gallnut according to different proportions is obviously higher than that of a single traditional Chinese medicine (crude drug dose is 1g/mL) of scutellaria baicalensis, honeysuckle, isatis root, fructus forsythiae, hawthorn, mint and gallnut, so that the antibacterial activity of escherichia coli can be obviously inhibited, and the antibacterial activity is obvious.
TABLE 4L 7(28) orthogonal test Table and inhibitory Effect on E.coli
Orthogonal experiment results of the antibacterial activity of the staphylococcus aureus are shown in table 5, the antibacterial zone of a traditional Chinese medicine composition (crude drug dose is 1g/mL) prepared by combining scutellaria baicalensis, honeysuckle, isatis root, fructus forsythiae, hawthorn, mint and gallnut according to different proportions to the staphylococcus aureus is obviously higher than that of a single traditional Chinese medicine (crude drug dose is 1g/mL) prepared from scutellaria baicalensis, honeysuckle, isatis root, fructus forsythiae, hawthorn and mint, the staphylococcus aureus can be obviously inhibited, and the antibacterial activity of the traditional Chinese medicine composition is obvious.
TABLE 5L7(28) Orthogonal test table and inhibitory effect on staphylococcus aureus
As can be seen from tables 4 and 5, the relationship that each factor affects the antibacterial effect of escherichia coli is a > D > F > G > C > B ═ E; B. e has a weak antibacterial effect on escherichia coli, and A, D has a strong antibacterial effect on escherichia coli, and the antibacterial effect of staphylococcus aureus is influenced by the factors of D > C > F > A > B and E-G. Therefore, B, E has weak bacteriostatic effect on escherichia coli and staphylococcus aureus, and A, D has certain inhibitory effect on escherichia coli and staphylococcus aureus. Through screening, the optimal mixture ratio obtained is A2B1C2D2E1F2G1, namely the mass ratio of fructus forsythiae, hawthorn, radix isatidis, gallnut, honeysuckle, scutellaria baicalensis and mint is 2: 1: 2: 2: 1: 2: 1, namely the traditional Chinese medicine composition 6, has obvious bacteriostatic effect on both escherichia coli and staphylococcus aureus.
MIC and MBC assays
Using a puncher to perform high-pressure sterilization on a circular filter paper sheet of filter paper for later use; preparing a drug stock solution by a test tube double dilution method according to different concentrations of drugs in the circular filter paper sheets, wherein the stock solution concentration is as follows: 500. 250, 125, 62.5, 31.25, 15.62, 7.81 and 3.91mg/mL, and soaking the circular filter paper sheet with the medicine liquid with different concentrations; and (3) taking 100 mu L of test bacterium liquid to a formed blank agar plate, uniformly coating the test bacterium liquid by using a bacterium coating rod, and flatly and sequentially pasting filter paper sheets soaked with different liquid medicine concentrations to the agar plate after the bacterium suspension on the plate is completely absorbed. And culturing the mixture in an incubator which is internally provided with filter paper sheets and is subjected to ultraviolet sterilization at 37 ℃ for 18-24 h within 15min, and reading and measuring the result. Taking the lowest concentration of a drug stock solution which does not generate an inhibition zone around a filter paper sheet (namely, inhibits the growth of a tested bacterium) as the lowest inhibition concentration (MIC) of the drug solution, inoculating the concentration of a culture solution which is generated by the inhibition zone on all K-B paper sheet methods on an agar plate, culturing for 24h at 37 ℃, and taking the lowest drug mass concentration of which the colony count is not more than 5 as the minimum bactericidal mass concentration (MBC) of the drug (namely, the general name of the lowest concentration of the drug for killing a certain strain).
The results are shown in table 6, wherein the mass ratio of fructus forsythiae, hawthorn, radix isatidis, gallnut, honeysuckle, scutellaria baicalensis and mint is 2: 1: 2: 2: 1: 2: 1 (10 mg of radix scutellariae, 5mg of honeysuckle, 10mg of radix isatidis, 10mg of fructus forsythiae, 5mg of hawthorn, 5mg of mint and 10mg of gallnut) has MIC (minimum inhibitory concentration) of 1.95mg/mL and 3.9mg/mL for escherichia coli and staphylococcus aureus; the MBC is 7.81mg/mL and 31.25mg/mL, and the MIC and the MBC are obviously reduced while the antibacterial effect is obvious.
TABLE 6 MIC and MBC determination (mg/mL) of Chinese medicinal composition 6 for different bacteria
Example 3 bacteriostatic activity of the Chinese medicinal composition with addition of fructus Schisandrae chinensis, cortex Cinnamomi, and radix Paeoniae alba
1. Preparation of Chinese medicinal composition with different proportions
The traditional Chinese medicine composition 9: the formula is as follows: 10mg of scutellaria baicalensis, 5mg of honeysuckle, 10mg of isatis root, 10mg of forsythia, 5mg of hawthorn, 5mg of mint, 10mg of gallnut, 10mg of schisandra chinensis, 5mg of cinnamon and 5mg of white paeony root;
10 of the traditional Chinese medicine composition: the formula is as follows: 10mg of scutellaria baicalensis, 5mg of honeysuckle, 10mg of isatis root, 10mg of forsythia, 5mg of hawthorn, 5mg of mint, 10mg of gallnut, 5mg of schisandra chinensis, 5mg of cinnamon and 5mg of white paeony root.
2. Zone of inhibition detection
Adopting agar plate punching method, uniformly coating 100 μ L of test bacteria on nutrient agar, standing for 15min, uniformly punching on nutrient agar with a puncher with diameter of 6mm, removing agar block, adding Chinese medicinal compound extractive solution containing crude drug 1g/mL into holes with liquid medicine overflow principle, 5 holes per plate, hole spacing >20mm, setting distilled water as negative control in the center, setting positive control, culturing at 37 deg.C for 24 hr, determining diameter of antibacterial ring, observing result, and repeating the test for 3 times. The bacteriostatic diameter is more than or equal to 20mm, the bacteriostatic diameter is extremely sensitive, the bacteriostatic diameter is 15-19 mm, the bacteriostatic diameter is highly sensitive, the bacteriostatic diameter is 10-14 mm, the bacteriostatic diameter is moderate sensitive, and the bacteriostatic diameter is less than 10mm, the bacteriostatic diameter is low sensitive.
The results of the zone of inhibition test are shown in table 7, and the traditional Chinese medicine composition formed by adding the schisandra chinensis, the cinnamon and the white paeony root on the basis of the scutellaria baicalensis, the honeysuckle, the isatis root, the forsythia suspensa, the hawthorn, the mint and the gallnut also has a certain inhibition effect, and the effect is equivalent to or better than that of the traditional Chinese medicine composition formed by the scutellaria baicalensis, the honeysuckle, the isatis root, the forsythia suspensa, the hawthorn, the mint and the gallnut.
TABLE 7 zone of inhibition (mm) of Chinese medicinal composition 11, 12 to different bacteria
MIC and MBC determination
Using a puncher to perform high-pressure sterilization on a circular filter paper sheet of filter paper for later use; preparing a drug stock solution by a test tube double dilution method according to different concentrations of drugs in the circular filter paper sheets, wherein the stock solution concentration is as follows: 500. 250, 125, 62.5, 31.25, 15.62, 7.81 and 3.91mg/mL, and soaking the circular filter paper sheet with the medicine liquid with different concentrations; and (3) taking 100 mu L of test bacterium liquid to a formed blank agar plate, uniformly coating the test bacterium liquid by using a bacterium coating rod, and flatly and sequentially pasting filter paper sheets soaked with different liquid medicine concentrations to the agar plate after the bacterium suspension on the plate is completely absorbed. And culturing the mixture in an incubator which is internally provided with filter paper sheets and is subjected to ultraviolet sterilization at 37 ℃ for 18-24 h within 15min, and reading and measuring the result. Taking the lowest concentration of a drug stock solution which does not generate an inhibition zone around a filter paper sheet (namely, inhibits the growth of a tested bacterium) as the lowest inhibition concentration (MIC) of the drug solution, inoculating the concentration of a culture solution which is generated by the inhibition zone on all K-B paper sheet methods on an agar plate, culturing for 24h at 37 ℃, and taking the lowest drug mass concentration of which the colony count is not more than 5 as the minimum bactericidal mass concentration (MBC) of the drug (namely, the general name of the lowest concentration of the drug for killing a certain strain).
The results are shown in table 8, and the traditional Chinese medicine composition formed by adding the schisandra chinensis, the cinnamon and the white paeony root on the basis of the scutellaria baicalensis, the honeysuckle, the isatis root, the fructus forsythiae, the hawthorn, the mint and the gallnut also has a certain antibacterial effect, obviously reduces the MIC and the MBC of a single traditional Chinese medicine while having an obvious antibacterial effect, and has an effect equivalent to or better than that of the traditional Chinese medicine composition formed by the scutellaria baicalensis, the honeysuckle, the isatis root, the fructus forsythiae, the hawthorn, the mint and the gallnut.
TABLE 8 MIC and MBC (mg/mL) of Chinese medicinal compositions 11 and 12 for different bacteria
Comparative example
1. Preparation of Chinese medicinal composition
Comparative composition 1: 10mg of scutellaria baicalensis, 5mg of honeysuckle, 10mg of isatis root and 10mg of gallnut;
comparative composition 2: 10mg of radix Scutellariae, 5mg of flos Lonicerae, and 10mg of Galla chinensis
Comparative composition 3: 10mg of radix scutellariae and 10mg of gallnut;
comparative composition 4: 10mg of scutellaria baicalensis, 5mg of honeysuckle and 10mg of forsythia;
2. zone of inhibition detection
Adopting agar plate punching method, uniformly coating 100 μ L of test bacteria on nutrient agar, standing for 15min, uniformly punching on nutrient agar with a puncher with diameter of 6mm, removing agar block, adding Chinese medicinal compound extractive solution containing crude drug 1g/mL into holes with liquid medicine overflow principle, 5 holes per plate, hole spacing >20mm, setting distilled water as negative control in the center, setting positive control, culturing at 37 deg.C for 24 hr, determining diameter of antibacterial ring, observing result, and repeating the test for 3 times. The bacteriostatic diameter is more than or equal to 20mm, the bacteriostatic diameter is extremely sensitive, the bacteriostatic diameter is 15-19 mm, the bacteriostatic diameter is highly sensitive, the bacteriostatic diameter is 10-14 mm, the bacteriostatic diameter is moderate sensitive, and the bacteriostatic diameter is less than 10mm, the bacteriostatic diameter is low sensitive.
The results of the detection of the inhibition zones are shown in table 9, and although the comparative composition has a certain inhibition effect on escherichia coli and staphylococcus aureus, the inhibition effect is significantly lower than that of the traditional Chinese medicine composition.
TABLE 9 zone of inhibition assay (mm) for comparative compositions
MIC and MBC determination
Using a puncher to perform high-pressure sterilization on a circular filter paper sheet of filter paper for later use; preparing a drug stock solution by a test tube double dilution method according to different concentrations of drugs in the circular filter paper sheets, wherein the stock solution concentration is as follows: 500. 250, 125, 62.5, 31.25, 15.62, 7.81 and 3.91mg/mL, and soaking the circular filter paper sheet with the medicine liquid with different concentrations; and (3) taking 100 mu L of test bacterium liquid to a formed blank agar plate, uniformly coating the test bacterium liquid by using a bacterium coating rod, and flatly and sequentially pasting filter paper sheets soaked with different liquid medicine concentrations to the agar plate after the bacterium suspension on the plate is completely absorbed. And culturing the mixture in an incubator which is internally provided with filter paper sheets and is subjected to ultraviolet sterilization at 37 ℃ for 18-24 h within 15min, and reading and measuring the result. Taking the lowest concentration of a drug stock solution which does not generate an inhibition zone around a filter paper sheet (namely, inhibits the growth of a tested bacterium) as the lowest inhibition concentration (MIC) of the drug solution, inoculating the concentration of a culture solution which is generated by the inhibition zone on all K-B paper sheet methods on an agar plate, culturing for 24h at 37 ℃, and taking the lowest drug mass concentration of which the colony count is not more than 5 as the minimum bactericidal mass concentration (MBC) of the drug (namely, the general name of the lowest concentration of the drug for killing a certain strain).
The results are shown in table 10, and the comparative composition has a certain bacteriostatic effect on escherichia coli and staphylococcus aureus, but the MIC and the MBC of the comparative composition are significantly higher than those of the traditional Chinese medicine composition.
TABLE 10 MIC, MBC (mg/mL) for comparative compositions to different bacteria
EXAMPLE 4 preparation of sprays
1. Preparation process
The formula is as follows: 10mg of radix scutellariae, 5mg of honeysuckle, 10mg of radix isatidis, 10mg of fructus forsythiae, 5mg of hawthorn, 5mg of mint and 10mg of gallnut
In the research of the formulation and the preparation process, the formulation is determined to be a solution type spray, and the types and the dosages of a solvent, a solubilizer, a cosolvent and a preservative are further researched by documents, wherein the test formula is as follows: adding 1% of tween-80, 5% of 1, 2-propylene glycol and 0.2% of benzoic acid into the 75% of alcohol-precipitated traditional Chinese medicine antibacterial solution.
The preparation method of the spray comprises adding benzoic acid into the Chinese medicinal antibacterial liquid under stirring in 40 deg.C water bath, mixing, adding tween-80 and 1, 2-propylene glycol, stirring, filtering, adding distilled water to full volume, and shaking.
The prepared antibacterial spray has natural and safe components, has stronger antibacterial action on escherichia coli, staphylococcus aureus and candida albicans, has light Chinese herbal medicine fragrance, light yellow and clear liquid medicine and fine and uniform aerial fog, is prepared from the traditional Chinese medicine composition with antibacterial activity, has the characteristics and advantages of atomized administration, avoids using a propellant, is safe and reliable, can suspend and stay for a long time, keeps the concentration of the traditional Chinese medicine disinfectant in the air, is particularly suitable for large-area disinfection and sterilization in hospitals, schools and the like, has the disinfection action, can purify air (make dust subside), humidify, scent air and other effects, and is also suitable for daily disinfection of skin and the like.
Claims (10)
1. The traditional Chinese medicine composition with bacteriostatic activity is characterized by comprising the following components in parts by mass: 1-2 parts of scutellaria baicalensis, 1-2 parts of honeysuckle, 1-2 parts of isatis root, 1-2 parts of fructus forsythiae, 1-2 parts of hawthorn, 1-2 parts of mint and 1-2 parts of gallnut.
2. The traditional Chinese medicine composition of claim 1, wherein the traditional Chinese medicine composition comprises the following components in parts by mass: 2 parts of scutellaria baicalensis, 1 part of honeysuckle, 2 parts of isatis root, 2 parts of fructus forsythiae, 1 part of hawthorn, 1 part of mint and 2 parts of gallnut.
3. The traditional Chinese medicine composition of claim 1, further comprising the following components in parts by mass: 1-2 parts of schisandra chinensis, 1-2 parts of cinnamon and 1-2 parts of white paeony root.
4. The traditional Chinese medicine composition of claim 3, which comprises the following components in parts by mass: : 2 parts of scutellaria baicalensis, 1 part of honeysuckle, 2 parts of isatis root, 2 parts of fructus forsythiae, 1 part of hawthorn, 1 part of mint, 2 parts of gallnut, 1 part of schisandra chinensis, 1 part of cinnamon and 1 part of radix paeoniae alba.
5. The method for preparing a Chinese medicinal composition according to any one of claims 1 to 4, wherein the method comprises the following steps: boiling the Chinese medicinal composition in water; filtering; heating and concentrating the filtrate to obtain the product.
6. The method of claim 5, comprising the steps of:
(1) taking the Chinese medicinal composition, adding ten times of distilled water, heating with strong fire to boil, and heating with slow fire for 1 hr;
(2) filtering, taking the dregs of a decoction, adding ten times of distilled water, and repeating the step (1);
(3) filtering, mixing filtrates, heating and concentrating to 1g/mL, standing at room temperature for 24h, centrifuging to obtain supernatant, and autoclaving.
7. The use of a Chinese medicinal composition as claimed in any one of claims 1 to 4 in the preparation of an antibacterial medicament.
8. The Chinese medicinal composition of any one of claims 1-4, wherein the Chinese medicinal composition is added with a pharmaceutically acceptable carrier to prepare any one pharmaceutically acceptable dosage form.
9. The Chinese medicinal composition of claim 8, wherein the dosage form comprises tablets, injections, oral liquids, and sprays.
10. The use of the Chinese medicinal composition of any one of claims 1-4 in the preparation of hand sanitizer and bacteriostatic soap.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111063207.XA CN113633685B (en) | 2021-09-10 | 2021-09-10 | Traditional Chinese medicine composition with antibacterial activity and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111063207.XA CN113633685B (en) | 2021-09-10 | 2021-09-10 | Traditional Chinese medicine composition with antibacterial activity and application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN113633685A true CN113633685A (en) | 2021-11-12 |
| CN113633685B CN113633685B (en) | 2022-05-17 |
Family
ID=78425571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111063207.XA Active CN113633685B (en) | 2021-09-10 | 2021-09-10 | Traditional Chinese medicine composition with antibacterial activity and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113633685B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114432387A (en) * | 2022-02-24 | 2022-05-06 | 河南科技学院 | Traditional Chinese medicine composition with antibacterial, anti-inflammatory and antiviral effects and preparation method and application thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101095721A (en) * | 2007-07-12 | 2008-01-02 | 辽宁省海洋水产科学研究院 | Sea cucumber Chinese medicinal herb preparations for preventing diseases and increasing the weight |
| CN113440563A (en) * | 2020-03-26 | 2021-09-28 | 浙江康恩贝制药股份有限公司 | Compound houttuynia cordata spray and preparation method and application thereof |
-
2021
- 2021-09-10 CN CN202111063207.XA patent/CN113633685B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101095721A (en) * | 2007-07-12 | 2008-01-02 | 辽宁省海洋水产科学研究院 | Sea cucumber Chinese medicinal herb preparations for preventing diseases and increasing the weight |
| CN113440563A (en) * | 2020-03-26 | 2021-09-28 | 浙江康恩贝制药股份有限公司 | Compound houttuynia cordata spray and preparation method and application thereof |
Non-Patent Citations (2)
| Title |
|---|
| 王嵩: "中草药抗细菌感染的研究", 《北京中医》 * |
| 王汉明等: "银蒲解毒含漱液对大鼠实验性牙周炎的治疗作用", 《临床口腔医学杂志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114432387A (en) * | 2022-02-24 | 2022-05-06 | 河南科技学院 | Traditional Chinese medicine composition with antibacterial, anti-inflammatory and antiviral effects and preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN113633685B (en) | 2022-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106538638B (en) | A kind of Chinese medicine antiseptic and preparation method thereof | |
| KR101796423B1 (en) | Composition and ladies genital area cleanser composition comprising composition for inducing Antiviral and antibacterial cause vaginitis and method for manufacturing the same | |
| CN104082353A (en) | Pure traditional Chinese medicine disinfectant and preparation method thereof | |
| CN104336078A (en) | Chlorine-containing Chinese herbal medicine air disinfectant, and preparation method and application thereof | |
| CN102697671B (en) | Bacterium and disease prevention wet wipe liquid medicament and preparation method thereof | |
| CN113244296B (en) | Medicinal volatile oil composition and preparation method and application thereof | |
| CN1173820A (en) | Pharmaceutical composition for the treatment of herpes | |
| CN104127779B (en) | A kind of Chinese herb compound washing lotion of anti-inflammation and preparation method thereof | |
| CN102512490A (en) | Aromatherapy essential oil for treating gynecological inflammation and essential oil aromatherapy patch | |
| CN113081928A (en) | Plant bacteriostatic gel and preparation method and application thereof | |
| CN111419947A (en) | Folium artemisiae argyi compound essential oil capable of relieving throat pain and preparation method thereof | |
| CN101283688B (en) | Pure Chinese medicine anti-avian influenza air disinfectant and its preparation method | |
| CN113633685B (en) | Traditional Chinese medicine composition with antibacterial activity and application | |
| CN102973973A (en) | Air-freshening bacteriostatic agent and preparation method thereof | |
| CN104922248A (en) | Antibacterial and anti-inflammatory Chinese herbal compound gel and preparation method thereof | |
| CN107952104A (en) | A kind of feminine hygiene articles for preventing menstruation infection and preparation method thereof | |
| CN110327222B (en) | Purely natural plant essential oil sterilization and disinfection wet tissue and preparation method thereof | |
| CN106806712A (en) | Skin bacteria inhibiting composition and preparation method thereof | |
| CN105287692A (en) | Dalbergia benthami prain extractive, and preparation method and application thereof | |
| CN105012581A (en) | Fresh aloe antibacterial composite, application and preparing method of fresh aloe antibacterial composite | |
| KR20170130690A (en) | Natural detergent composition and preparation method thereof | |
| CN111714674B (en) | Traditional Chinese medicine volatile oil and preparation method and application thereof | |
| CN103263679B (en) | The preparation method of the fragrant plant air scavenging solution of medicine of environment purification, strengthening respiratory system | |
| CN101422419B (en) | Toilet water and manufacture method thereof | |
| CN102824448B (en) | A kind of prevention and/or the pharmaceutical composition for the treatment of gynaecopathia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |